galactosamine has been researched along with acetovanillone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, J; Gong, X; Huang, J; Li, L; Lin, L; Peng, X; Shen, Y; Tang, L; Wan, J; Yang, Y; Zhang, L | 1 |
| Abdelaziz Shaaban, A; Ibrahim Abu Hashim, I; Mohamed Anter, H; Mohamed Meshali, M; Mokhtar Aman, R | 1 |
2 other study(ies) available for galactosamine and acetovanillone
| Article | Year |
|---|---|
Therapeutic benefits of apocynin in mice with lipopolysaccharide/D-galactosamine-induced acute liver injury via suppression of the late stage pro-apoptotic AMPK/JNK pathway.
Topics: Acetophenones; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Apoptosis; Biopsy; Caspases; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Enzyme Inhibitors; Galactosamine; Hepatocytes; Immunohistochemistry; Lipopolysaccharides; MAP Kinase Signaling System; Mice; Oxidative Stress; Phosphorylation; Reactive Oxygen Species | 2020 |
Propitious maneuvering for delivery of the phytopharmaceutical "apocynin" to induced fulminant hepatitis in BALB/c mice: In vitro and in vivo assessments.
Topics: Acetophenones; Animals; Antioxidants; Chitosan; Emulsions; Galactosamine; Lipopolysaccharides; Massive Hepatic Necrosis; Mice; Mice, Inbred BALB C; NADP; Nanoparticles; Oxidoreductases; Particle Size; Phytochemicals; Polylactic Acid-Polyglycolic Acid Copolymer; Polyvinyl Alcohol; Solvents | 2022 |